India · English
Cancer drug prices likely to fall as govt caps trade margins at 30%
The move could reduce the MRP of affected medicines by up to 70 per cent and result in annual savings of around Rs ₹2,500 crore for patients undergoing cancer treatment
Read the full report at The Hindu BusinessLine →
How 3 newsrooms ran it
3 of our sources carried this story over 3.4 hours. The Hindu BusinessLine filed first, at 18:44 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 18:44 | The Hindu BusinessLine | Cancer drug prices likely to fall as govt caps trade margins at 30% |
| 22:00 | New Indian Express | Cancer drugs to get 70% cheaper as centre plans to cap trade margins |
| 22:09 | The Hindu National | Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.